Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02627352 · ClinicalTrials.gov registry record · NA
How Safe and Effective is Micropulse Transscleral Cyclophotocoagulation in Patients With Uncontrolled Glaucoma?
A NA study, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT02627352 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 15 participants.
The verdict
NCT02627352, a NA study, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the surgical outcomes of the micropulse transscleral cyclophotocoagulation (mTSCPC) in patients with uncontrolled glaucoma; analyze intraocular pressure lowering effect; and correlate related treatment parameters pending enrollment of sufficient numbers of dark pigmented versus light pigmented eyes.
Interventions
- PROCEDURE Micropulse Transscleral Cyclophotocoagulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02627352
The ClinicalTrials.gov registry entry for NCT02627352 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Micropulse Transscleral Cyclophotocoagulation is the first listed.
NCT02627352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02627352 about?
NCT02627352 is a clinical study titled "How Safe and Effective is Micropulse Transscleral Cyclophotocoagulation in Patients With Uncontrolled Glaucoma?". The purpose of this study is to investigate the surgical outcomes of the micropulse transscleral cyclophotocoagulation (mTSCPC) in patients with uncontrolled glaucoma; analyze intraocular pressure lowering effect; and correlate related treatment parameters pending enrollment of sufficient numbers of...
What is the current status of trial NCT02627352?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2014-02. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02627352?
The interventions under investigation include: Micropulse Transscleral Cyclophotocoagulation (PROCEDURE).
Who is sponsoring clinical trial NCT02627352?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.